[go: up one dir, main page]

UY26605A1 - CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INGESTION OF CIPROFLOXACIN - Google Patents

CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INGESTION OF CIPROFLOXACIN

Info

Publication number
UY26605A1
UY26605A1 UY26605A UY26605A UY26605A1 UY 26605 A1 UY26605 A1 UY 26605A1 UY 26605 A UY26605 A UY 26605A UY 26605 A UY26605 A UY 26605A UY 26605 A1 UY26605 A1 UY 26605A1
Authority
UY
Uruguay
Prior art keywords
ciprofloxacin
oral administration
administration system
agent
daily ingestion
Prior art date
Application number
UY26605A
Other languages
Spanish (es)
Inventor
Naresh Talwar
John Staniforth
Ashok Rampal
Gour Mukherji
Badri VISHWANATHAN
Brij Hkera
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to UY26605A priority Critical patent/UY26605A1/en
Publication of UY26605A1 publication Critical patent/UY26605A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una fórmula contenida en una tableta diaria para administración oral a humanos para la liberación controlada de Ciprofloxacina, que comprende una cantidad de Ciprofloxacina farmacéuticamente efectiva, desde alrededor de 0.1% hasta alrededor de 0.8% de un agente viscolizante y/o un agente de gelación, alrededor de 0.5% hasta alrededor de 15% de un agente generador de gas (efervescencia), y alrededor de 3.0% hasta alrededor de 15% de un agente de expansión. Estando dichos porcentajes en relación de peso / peso del compuesto.A formula contained in a daily tablet for oral administration to humans for the controlled release of Ciprofloxacin, comprising a pharmaceutically effective amount of Ciprofloxacin, from about 0.1% to about 0.8% of a viscolyzing agent and / or a gelation agent, about 0.5% to about 15% of a gas generating agent (effervescence), and about 3.0% to about 15% of a blowing agent. Said percentages being in weight / weight ratio of the compound.

UY26605A 2001-03-02 2001-03-02 CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INGESTION OF CIPROFLOXACIN UY26605A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY26605A UY26605A1 (en) 2001-03-02 2001-03-02 CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INGESTION OF CIPROFLOXACIN

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY26605A UY26605A1 (en) 2001-03-02 2001-03-02 CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INGESTION OF CIPROFLOXACIN

Publications (1)

Publication Number Publication Date
UY26605A1 true UY26605A1 (en) 2001-10-25

Family

ID=38812358

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26605A UY26605A1 (en) 2001-03-02 2001-03-02 CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INGESTION OF CIPROFLOXACIN

Country Status (1)

Country Link
UY (1) UY26605A1 (en)

Similar Documents

Publication Publication Date Title
BR0003158A (en) Instant melting oral dosage formulation
ATE293995T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS THAT PROMOTE DRUG ABSORPTION
NO993520L (en) Dosage forms and methods for better erectile dysfunction
BR0215380A (en) Pharmaceutical or nutraceutical micronized powder for immediate release and use thereof
CL2009001682A1 (en) Spontaneously dispersible pharmaceutical composition for oral administration comprising n-benzoyl-staurosporine; method to increase levels of bioavailability. (divisional of only 333-00).
CY1105908T1 (en) BENZIMIDAZOLE ORODICALLY DISPERSIBLE TABLETS
BR0215184A (en) orally active taxane derivative pharmaceutical compositions having increased bioavailability
BG66093B1 (en) Controlled release compositions comprising nimesulide
DE50203456D1 (en) DEUTERATED 3-PIPERIDINOPROPIOPHENONE AND MEDICAMENTS CONTAINING SUCH COMPOUNDS
BR0209283A (en) Method for the manufacture of a low dosage pharmaceutical composition having uniform drug distribution and potency
MD2447F2 (en) Pharmaceutical composition, use thereof and methods of treatment of cephalalgia, migraine, sickness and vomiting
BRPI0408655A (en) formulations comprising an active agent and cocoa powder and their use
PT1425005E (en) PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS LUMIRACOXIB
PL402550A1 (en) Intravaginal pharmaceutical composition and the use of a peroxide source and a bioadhesive carrier
MY129314A (en) Pharmaceutical composition comprising sumatriptan
ES2130081B1 (en) TRIMEBUTINE MALEATE TABLET WITH LAMINAR COATING.
ECSP013952A (en) CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INTAKE OF CIPROFLOXACINE
BRPI0414305A (en) oral drug delivery system
BR0307320A (en) Osmotic release system
BR0209155A (en) Pharmaceutical tablet having a high api content
UY26605A1 (en) CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INGESTION OF CIPROFLOXACIN
GEP20043377B (en) Pharmaceutical Complex
UY26176A1 (en) POLYMORPHIC FORMS OF A AZOBICICLO CITRATE (2,2,2) OCTAN-3-AMINE AND ITS PHARMACEUTICAL COMPOSITIONS.
ATE261732T1 (en) PHARMACEUTICAL COMPOSITION COMPRISING EUCALYPTUS AND ORANGE OIL
SV2003000335A (en) CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INTAKE OF CIPROFLOXACINE

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20120611